[Nephrogenic systemic fibrosis].
A scleromyxedema-like disease was recognized in 1997. In 2000 this disorder was first published and termed nephrogenic fibrosing dermopathy because all patients had advanced renal failure. In 2006 it was discovered that the patients had a history of a preceding contrast-enhanced magnetic resonance imaging (MRI). All patients had acute or chronic severe renal insufficiency with a glomerular filtration rate (GFR) <30 ml/min per 1.73 m(2). So far a total of about 215 patients with this new skin disorder have been reported to international registries. The skin thickening has a typical histology and begins in the peripheral extremities and progresses proximally, including also the abdominal wall and the head in some patients. NSF involves not only the skin, but also the muscles and other organs (e.g., lungs, heart, eyes) in some patients. Therefore the term nephrogenic systemic fibrosis (NSF) was introduced. Skin fibrosis and sclerosis are usually progressive with disabling contractures of involved joints (knees, hands, feet). NSF may be lethal in up to 28% of patients. Spontaneous remissions are rare. No generally accepted treatment is available. So far, the pathogenesis is not well understood. One hypothesis supposes a role of gadolinium liberated from the contrast agents. As patients with acute or chronic advanced renal failure (GFR <30 ml/min per 1.73 m(2)) including those with hepatorenal dysfunctions are at high risk to develop NSF after exposure to gadolinium-based contrast agents, contrast-enhanced MRI should be avoided in this group and alternative diagnostic procedures should be used whenever possible.
Samtleben
W
W
Schwerpunkt Nephrologie, Medizinische Klinik und Poliklinik I, Klinikum Grosshadern der Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 München, Deutschland. walter.samtleben@med.uni-muenchen.de
D003287:Contrast Media / Q000009:adverse effects*; D018450:Disease Progression; D005355:Fibrosis / Q000139:chemically induced / Q000473:pathology; D019786:Gadolinium DTPA / Q000009:adverse effects*; D005919:Glomerular Filtration Rate; D006801:Humans; D016030:Kidney Transplantation; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications* / Q000628:therapy; D012307:Risk Factors; D053718:Scleromyxedema / Q000139:chemically induced*; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
D003287:Contrast Media; D019786:Gadolinium DTPA
Am J Clin Dermatol. 2006;7(4):237-47
16901184
Br J Dermatol. 2003 Mar;148(3):563-8
12653751
Nephrol Dial Transplant. 2006 Apr;21(4):1104-8
16431890
Clin Exp Dermatol. 2004 May;29(3):258-60
15115505
Ann Intern Med. 1999 Mar 16;130(6):461-70
10075613
J Vasc Interv Radiol. 2007 Mar;18(3):331-3
17377176
Semin Dial. 2003 May-Jun;16(3):276-80
12753692
Invest Radiol. 1996 Oct;31(10):619-24
8889650
Am J Dermatopathol. 2003 Jun;25(3):204-9
12775982
Methods Find Exp Clin Pharmacol. 1996 Sep;18(7):437-42
8900215
Br J Dermatol. 2004 Mar;150(3):596-7
15030351
AJR Am J Roentgenol. 2007 Feb;188(2):586-92
17242272
Int J Dermatol. 2007 May;46(5):447-52
17472669
J Am Soc Nephrol. 2006 Sep;17(9):2359-62
16885403
Br J Dermatol. 2005 Mar;152(3):531-6
15787823
Dermatology. 2004;209(1):50-2
15237268
J Am Acad Dermatol. 2007 Jan;56(1):21-6
17097388
Lancet. 2000 Sep 16;356(9234):1000-1
11041404
Fundam Clin Pharmacol. 2006 Dec;20(6):563-76
17109649
Curr Opin Rheumatol. 2003 Nov;15(6):785-90
14569211
Radiat Med. 2006 Jul;24(6):445-51
16958426
Am J Kidney Dis. 2005 Oct;46(4):763-5
16183434
Am J Dermatopathol. 2001 Oct;23(5):383-93
11801769
Nephrol Dial Transplant. 2005 Jan;20(1):220-2
15632355
Nephron. 1976;16(1):31-41
1244564
Invest Radiol. 2007 Feb;42(2):139-45
17220732
J Pediatr. 2003 Nov;143(5):678-81
14615747
Arch Dermatol. 2003 Jul;139(7):903-6
12873886
J Am Acad Dermatol. 2007 Jan;56(1):27-30
17109993
Semin Arthritis Rheum. 2006 Feb;35(4):238-49
16461069
Acta Radiol. 2001 May;42(3):339-41
11350296
Acad Radiol. 1998 Jul;5(7):491-502
9653466
Arch Pathol Lab Med. 2006 Feb;130(2):209-12
16454565
Dermatology. 2004;208(3):278-80
15118390
Am J Med. 2003 May;114(7):563-72
12753880